Bone morphogenetic protein 10 (BMP10), a novel member of BMP family, has been identified as an important regulator for angiogenesis. Dysregulation of BMP has been observed in several cancer types. However, its roles in gastric cancer (GC) remain unknown. In this study, the expression of BMP10 was found to be down-regulated in GC samples. Forced expression of BMP10 in GC cells inhibited its growth and migration, while knocking down the expression of BMP10 in GC cells promoted cell growth, migration, and metastasis. BMP10 was shown to negatively regulated beta-catenin/TCF signaling by up-regulating Axin protein level. Taken together, the present study revealed the suppressive function of BMP10 in gastric cancer.
BMP10 Beta-catenin/TCF signaling Axin Cell growth and migration
This is a preview of subscription content, log in to check access.
Bazas VM, Lukyanova NY, Lisovenko GS, Rozumiy DO, Potebnya GP. Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue. Exp Oncol. 2009;31:182–4.PubMedGoogle Scholar
Schuetz JM, Leach S, Kaurah P, et al. Catenin family genes are not commonly mutated in hereditary diffuse gastric cancer. Cancer Epidemiol Biomarkers Prev. 2012;21:2272–4.CrossRefPubMedGoogle Scholar
David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S. Identification of bmp9 and bmp10 as functional activators of the orphan activin receptor-like kinase 1 (alk1) in endothelial cells. Blood. 2007;109:1953–61.CrossRefPubMedGoogle Scholar
Mazerbourg S, Hsueh AJ. Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands. Hum Reprod Update. 2006;12:373–83.CrossRefPubMedGoogle Scholar
Zhang N, Ye L, Wu L, et al. Expression of bone morphogenetic protein-10 (bmp10) in human urothelial cancer of the bladder and its effects on the aggressiveness of bladder cancer cells in vitro. Anticancer Res. 2013;33:1917–25.PubMedGoogle Scholar
Ye L, Bokobza S, Li J, et al. Bone morphogenetic protein-10 (bmp-10) inhibits aggressiveness of breast cancer cells and correlates with poor prognosis in breast cancer. Cancer Sci. 2010;101:2137–44.CrossRefPubMedGoogle Scholar
Kang MH, Oh SC, Lee HJ, et al. Metastatic function of bmp-2 in gastric cancer cells: the role of pi3k/akt, mapk, the nf-kappab pathway, and mmp-9 expression. Exp Cell Res. 2011;317:1746–62.CrossRefPubMedGoogle Scholar
Park Y, Kim JW, Kim DS, et al. The bone morphogenesis protein-2 (bmp-2) is associated with progression to metastatic disease in gastric cancer. Cancer Res Treat. 2008;40:127–32.CrossRefPubMedPubMedCentralGoogle Scholar
Katoh M, Terada M. Overexpression of bone morphogenic protein (bmp)-4 mrna in gastric cancer cell lines of poorly differentiated type. J Gastroenterol. 1996;31:137–9.CrossRefPubMedGoogle Scholar
Kang MH, Kim JS, Seo JE, Oh SC, Yoo YA. Bmp2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (pi3k)/akt pathway. Exp Cell Res. 2010;316:24–37.CrossRefPubMedGoogle Scholar
Villacorte M, Suzuki K, Hayashi K, et al. Antagonistic crosstalk of wnt/beta-catenin/bmp signaling within the apical ectodermal ridge (aer) regulates interdigit formation. Biochem Biophys Res Commun. 2010;391:1653–7.CrossRefPubMedGoogle Scholar
Liu Z, Tang Y, Qiu T, Cao X, Clemens TL. A dishevelled-1/smad1 interaction couples wnt and bone morphogenetic protein signaling pathways in uncommitted bone marrow stromal cells. J Biol Chem. 2006;281:17156–63.CrossRefPubMedGoogle Scholar
Tian YC, Phillips AO. Interaction between the transforming growth factor-beta type ii receptor/smad pathway and beta-catenin during transforming growth factor-beta1-mediated adherens junction disassembly. Am J Pathol. 2002;160:1619–28.CrossRefPubMedPubMedCentralGoogle Scholar